EFFECTS OF BLOCKADE OF 5-HT2 RECEPTORS AND ACTIVATION OF 5-HT1A RECEPTORS ON THE EXPLORATORY ACTIVITY OF RATS IN THE ELEVATED PLUS-MAZE

被引:56
|
作者
MOTTA, V [1 ]
MAISONNETTE, S [1 ]
MORATO, S [1 ]
CASTRECHINI, P [1 ]
BRANDAO, ML [1 ]
机构
[1] UNIV SAO PAULO,FAC FILOSOFIA CIENCIAS & LETRAS RIBEIRAO PRETO,PSICOBIOL LAB,BR-14049 RIBEIRAO PRETO,SP,BRAZIL
关键词
5-HT1A RECEPTORS; 5-HT2; RECEPTORS; ANXIETY; GEPIRONE; KETANSERIN; PLUS-MAZE TEST;
D O I
10.1007/BF02244978
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acute administration of gepirone, a 5-HT1A agonist, caused a dose dependent (1-10 mg/kg, IP) reduction in the locomotor activity (open and closed arms) of rats tested in the elevated plus-maze. However, rats housed in individual cages and submitted to chronic treatment with gepirone (10 mg/kg PO) showed a marked increase in the percentages of number and time spent in the open arms as compared to controls. These results are compatible with the idea that the antiaversive effect due to long-term treatment with 5-HT1A agonists is the result of a progressive desensitization of the somatodendritic 5-HT autoreceptor with the consequent recovery of firing rate of 5-HT neurons along with an activation of normosensitive postsynaptic 5-HT neurons. Ketanserin caused a biphasic effects on the exploratory behavior of rats in the plus-maze. The lower dose (0.5 mg/kg) decreased the aversion to the open arms and the higher dose (1.0 mg/kg) caused an unspecific decrease in the overall activity of the animals. Ketanserin is supposed to have antagonistic action on 5-HT2 and on alpha-adrenergic receptors. As prazosin (0.5-1.0 mg/kg), an alpha-adrenergic receptor blocker, did not present any significant effect in the present work it is suggested that the effects of the lower dose of ketanserin was due to its high antagonistic action on 5-HT2 receptors.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 50 条
  • [1] INVOLVEMENT OF 5-HT1A AND 5-HT2 RECEPTORS OF THE INFERIOR COLLICULUS IN AVERSIVE STATES INDUCED BY EXPOSURE OF RATS TO THE ELEVATED PLUS-MAZE TEST
    MELO, LL
    BRANDAO, ML
    BEHAVIOURAL PHARMACOLOGY, 1995, 6 (04): : 413 - 417
  • [2] Evidence for a functional interaction between 5-HT1A and 5-HT2 receptors in rats
    Kirsten Krebs-Thomson
    M. A. Geyer
    Psychopharmacology, 1998, 140 : 69 - 74
  • [3] Evidence for a functional interaction between 5-HT1A and 5-HT2 receptors in rats
    Krebs-Thomson, K
    Geyer, MA
    PSYCHOPHARMACOLOGY, 1998, 140 (01) : 69 - 74
  • [4] The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats
    Krebs-Thomson, Kirsten
    Ruiz, Erbert M.
    Masten, Virginia
    Buell, Mahalah
    Geyer, Mark A.
    PSYCHOPHARMACOLOGY, 2006, 189 (03) : 319 - 329
  • [5] The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats
    Kirsten Krebs-Thomson
    Erbert M. Ruiz
    Virginia Masten
    Mahalah Buell
    Mark A. Geyer
    Psychopharmacology, 2006, 189 : 319 - 329
  • [6] DIFFERENTIAL INTERACTIONS OF DIMETHYLTRYPTAMINE (DMT) WITH 5-HT1A AND 5-HT2 RECEPTORS
    DELIGANIS, AV
    PIERCE, PA
    PEROUTKA, SJ
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (11) : 1739 - 1744
  • [7] 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze
    Gonzalez, LE
    Andrews, N
    File, SE
    BRAIN RESEARCH, 1996, 732 (1-2) : 145 - 153
  • [8] BRAIN 5-HT1A, 5-HT1D, AND 5-HT2 RECEPTORS IN SUICIDE VICTIMS
    ARRANZ, B
    ERIKSSON, A
    MELLERUP, E
    PLENGE, P
    MARCUSSON, J
    BIOLOGICAL PSYCHIATRY, 1994, 35 (07) : 457 - 463
  • [9] The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze
    Sakaue, M
    Ago, Y
    Sowa, C
    Koyama, Y
    Baba, A
    Matsuda, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 458 (1-2) : 141 - 144
  • [10] 5-HT1A AND 5-HT2 RECEPTORS MEDIATE HYPOTHERMIC AND HYPERTHERMIC EFFECTS OF TRYPTOPHAN IN PARGYLINE-PRETREATED RATS
    ABDELFATTAH, AFM
    MATSUMOTO, K
    ELHADY, KAW
    WATANABE, H
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 52 (02) : 379 - 384